Type / Class
Equity / Class A ordinary share, par value $0.0001
Shares outstanding
17.3M
Number of holders
42
Total 13F shares, excl. options
15M
Shares change
+14.9M
Total reported value, excl. options
$151M
Value change
+$150M
Number of buys
41
Price
$10.02

Significant Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q4 2024

42 filings reported holding TDACU - Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 as of Q4 2024.
Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15M shares of 17.3M outstanding shares and own 87.05% of the company stock.
Largest 10 shareholders include AQR Arbitrage LLC (1.49M shares), Magnetar Financial LLC (1.3M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (900K shares), LMR Partners LLP (800K shares), Polar Asset Management Partners Inc. (800K shares), K2 PRINCIPAL FUND, L.P. (675K shares), First Trust Capital Management L.P. (650K shares), Hudson Bay Capital Management LP (650K shares), TENOR CAPITAL MANAGEMENT Co., L.P. (635K shares), and Crossingbridge Advisors, LLC (600K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.